Skip to main content
TipRanks
Go Ultimate75% OFF

Novo Nordisk (NVO) Revenue by Segment

15,210 Followers

Revenue by Segment

In Q3 2026, Novo Nordisk reported revenue by segment of kr47.55B (Diabetes), kr26.15B (Obesity) and kr5.50B (Rare Disease).

Details revenue from various business segments, providing insight into Novo Nordisk's diverse income streams and strategic focus areas.

kr0.00kr20.00Bkr40.00Bkr60.00Bkr80.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Novo’s revenue mix is visibly shifting: Diabetes remains the largest, but growth is now more muted and lumpy, while the obesity franchise has surged since 2022 to become the company’s primary growth engine. Rare disease sales are steady but too small to move the needle. That trade-off boosts upside from blockbuster obesity drugs but raises concentration risk—future results will hinge on continued market adoption, pricing dynamics and competitive/regulatory pressure in the GLP‑1 space.

NVO Revenue by Segment

PeriodDiabetesObesityRare Disease
Q3 2026Sep 30, 2026kr47.55Bkr26.15Bkr5.50B
Q2 2026Jun 30, 2026kr50.43Bkr23.15Bkr4.91B
Q1 2026Mar 31, 2026kr44.94Bkr20.91Bkr4.21B
Q4 2025Dec 31, 2025kr51.35Bkr22.45Bkr5.35B
Q3 2025Sep 30, 2025kr49.15Bkr21.11Bkr4.72B
Q2 2025Jun 30, 2025kr51.57Bkr20.37Bkr4.92B
Q1 2025Mar 31, 2025kr55.04Bkr18.42Bkr4.62B
Q4 2024Dec 31, 2024kr58.57Bkr21.41Bkr5.71B
Q3 2024Sep 30, 2024kr47.94Bkr18.80Bkr4.57B
Q2 2024Jun 30, 2024kr50.18Bkr13.90Bkr3.98B
Q1 2024Mar 31, 2024kr49.93Bkr11.04Bkr4.38B
Q4 2023Dec 31, 2023kr50.06Bkr11.23Bkr4.57B
Q3 2023Sep 30, 2023kr42.57Bkr12.26Bkr3.90B
Q2 2023Jun 30, 2023kr39.88Bkr10.31Bkr4.11B
Q1 2023Mar 31, 2023kr40.95Bkr7.84Bkr4.58B
Q4 2022Dec 31, 2022kr37.75Bkr5.49Bkr4.85B
Q3 2022Sep 30, 2022kr36.13Bkr4.33Bkr5.11B
Q2 2022Jun 30, 2022kr32.40Bkr3.64Bkr5.22B
Q1 2022Mar 31, 2022kr33.27Bkr3.40Bkr5.36B
Q4 2021Dec 31, 2021kr31.16Bkr2.46Bkr4.71B
Q3 2021Sep 30, 2021kr28.72Bkr2.40Bkr4.51B
Q2 2021Jun 30, 2021kr26.04Bkr1.99Bkr5.01B
Q1 2021Mar 31, 2021kr27.28Bkr1.55Bkr4.98B
Q4 2020Dec 31, 2020kr23.61Bkr1.21Bkr4.47B
Q3 2020Sep 30, 2020kr23.77Bkr1.46Bkr4.80B
Q2 2020Jun 30, 2020kr24.01Bkr1.44Bkr4.82B
Q1 2020Mar 31, 2020kr25.77Bkr1.56Bkr5.09B
Q4 2019Dec 31, 2019kr27.01Bkr1.58Bkr5.28B
Q3 2019Sep 30, 2019kr24.01Bkr1.31Bkr4.69B
Q2 2019Jun 30, 2019kr25.01Bkr1.34Bkr4.58B
Q1 2019Mar 31, 2019kr26.38Bkr1.39Bkr4.37B

Related KPIs